Omega-3 and omega-6 fatty acids

Nutrition and Metabolic Disorders in HIV Infection

Volumn 6, Issue 3, 2007, Pages 1165-1169

  Candela, Carmen Gómez ^a   Rabaneda, Rosa Castillo ^a   Dassen, Carolina ^a   Borje, Virginia Martín ^a   Lobo, Raquel Mateo ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; CORTICOSTEROID; ICOSANOID; INTERLEUKIN 1; LEUKOTRIENE; LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN; THROMBOXANE; TUMOR NECROSIS FACTOR;

ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CROHN DISEASE; DRUG DOSE REDUCTION; DRUG POTENCY; DRUG STRUCTURE; FATTY ACID SYNTHESIS; HEART PROTECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; RECURRENT DISEASE; REVIEW; ULCERATIVE COLITIS; VASODILATATION;

EID: 40749120954     PISSN: 15797376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Palella FG, Delaney KM, Moorman A et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1988;338:853-60.
2. Conejero M, Tural C, Jou A et al. Reduction in progression to AIDS and death since the introduction of protease inhibitors. 37th ICAAC, 28 September-1st October 1997. Toronto, Canada (Abstract I-181).
3. Deeks SG, Smith M, Kahn JO. HIV-1 Protease inhibitors. JAMA. 1997;277:145-153
4. Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nat Med. 1995;1:41722.
5. Brinkman K, Ter Hofstede HJM, Burger DM, Smeitiak JA, Koopman PP. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS. 1998;12 (14):1735-44.
6. Safrin S, Grunfeld C. Fat distribution and metabolic changes in patients with HIV infection. AIDS. 1999;13: 2493-505.
7. Sanders TA. Polyunsaturated fatty acids in the foodchain in Europe. Am J Clin Nutr. 2000;71:176s-80s.
8. Connor WE: Importance of n-3 fatty acids in health and disease. Am J Clin Nutr. 2000;71:171S-5S.
9. Zampelas A, Roche H, Knapper JM et al. Differences in postprandial lipemic response between Northern and Southern Europeans. Atherosclerosis 1998;139:8393.
10. Visioli F, Rise P, Plasmati E, Pazzucconi F, Sirtori CR, Galli C. Very low intakes of n-3 fatty acids incorporated into bovine milk reduce plasma triacylglycerol and increase HDL-cholesterol concentrations in healthy subjects. Pharmacol Res. 2000;41:571-6.
11. Appel LJ, Miller ER III, Seidler AJ, Whelton PK. Does supplementation of diet with "fish oil" reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Int Med. 1993;153:429-38.
12. Morris MC, Sacks F, Rosner B: Does fish oil lower blood pressure? A metaanalysis of controlled trials. Circulation. 1993;88:523-33.
13. Angerer P, Von Schacky C, n-3 polyunsaturated fatty acids and the cardiovascular system. Curr Opin Lipidol. 2000;11:57-63.
14. Simopoulos AP, Leaf A, Salem N Jr. Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Am Nutr Metab. 1999;43:127-30.
15. Report of a Joint Expert Consultation: Diet, nutrition and the prevention of chronic diseases. WHO Technical Report Series 916. FAO/ WHO, Geneva, 2003.
16. Kris-Etherton PM, Harris WS, Appel LJ. AHA Nutrition Committee. American Heart Association: Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003;23:151-2.
17. Kris-Etherton PM, Taylor DS, Yu-Poth S et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr. 2000;71:179s-88s.
18. ASPEN board of directors. Guidelines for the use of parenteral and enteral nutrition: Specific guidelines for disease in adults. JPEN. 2002;26:61-97
19. De Luis DA, Aller R, Bachiller P, Eiros Bouzas JM, Arranz M et al. Nutritional treatment for acquired immunodeficiency virus infection using an enterotropic peptide-based formula enriched with n-3 fatty acids: a randomized prospective trial. Eur J Clini Nutrition. 2001;55:1048-52.
20. De Luis DA, Bachiller P, Izaola O, Eiros Bouza JM. Relación de la ingesta de ácidos grasos omega-3 y los valores de CD4 en pacientes con infección por VIH: un estudio transversal. An Med Interna. Vol. 22, no. 7. Madrid Jul 2005.
21. Endres S, Ghorbani R, Keley VE. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and TNF alpha by mononuclear cells. N Engl J Med. 1989;320:265-8.
22. Hellerstein MK, Wu K, McGrath M, Faix D, George D, Shackleton CH, Horn W, Hoh R, Neese PA. Effects of dietary n-3 fatty acids supplementation in men with weight loss associated with the acquired immune deficiency syndrome: Relation to indices of cytokine production. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Mar 1;11(3):258-70
23. De Truchis P, Kirstetter M, Perier A, Meunier C, Gardette J, Melchior JC. Treatment of hypertrigliceridemia in HIV-infected patients under HAART, by (n-3) polyunsaturated fatty acids: A double-blind randomized prospective trial in 122 patients. 12th Conference on Retroviruses and Opportunistic Infections. Boston, 22-25 February, 2005. Abstract 39.
24. Woods MN. Role of n-3 fatty acids in prevention of disease complications in patients with HIV. Nutr Clin Care. 2005 Jan-Mar;8(1):24-30.
25. Manfredi R, Calza L, Chiodo F. Polyunsaturated ethyl esters of n-3 fatty acids in HIV-infected patients with moderate hypertriglyceridemia: comparison with dietary and lifestyle changes, and fibrate therapy. Journal of Acquir Immune Defic Syndr. Vol 36 (3) 1 July 2004.